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ABSTRACT: Whether or not low CD4 count directly contributes to stroke among HIV infected stroke patients is yet 
to be elucidated. This study aimed to ascertain the role of low CD4 count in the pathophysiology of stroke in HIV 
infection. This was a hospital-based, case-control study. Sixty five (65) consecutive stroke patients (36 males and 
29 females) aged 20-68 years and sixty five (65) age-and-sex matched controls were enrolled. A structured 
questionnaire was administered. Neurological examination was performed and computed tomography scan of the 
brain done. Blood samples were taken for HIV 1&2 screening using ELISA method. Positive test using two 
different kits constituted a positive result. CD4 count was determined by western blot method. The mean CD4 count 
of HIV positive stroke patients (224.92 cells/cm3) is significantly lower (P <0.001) than that of HIV negative patients 
(690.67 cells/cm3). Nine out of thirteen (9/13, 69%) HIV positive stroke patients have CD4 <200 cells/µl. In addition 
to the conventional risk factors for ischemic stroke in HIV-infected patients, immune dysfunction (low CD4 count) is 
an important and significant modifiable risk factor of ischemic stroke event among HIV infected adult population of 
Northeastern Nigeria. Consequently, better understanding and awareness of the role of low CD4 count in the 
pathogenesis of stroke among HIV adults in this environment may provide a roadmap for controlling one of the 
deleterious non-opportunistic neurologic complication of HIV infection 
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INTRODUCTION 
Infection with HIV causes immune deficiency to a large 
extent by decreasing the level and function of CD4 T-
lymphocytes. This effect is accompanied by activation 
of the immune system, leading to a functional 
immunosuppression and a state of inflammation and 
coagulation, which in turns increases the risk of non-
opportunistic complications such as stroke (Tipping et 
al., 2007a). HIV-associated immune activation may also 
occur due to intimal response to transendothelial 
migration by neurotropic HIV strains causing 
intracranial vasculopathy (Mazzoni et al., 2000) There 
are reported cases of intracranial vasculopathy 
secondary to immunocompromised state with low CD4 
counts; typified by intimal hyperplasia, fibrosis, 
thickened beaded internal elastic lamina and 
fragmentation (Tipping et al., 2007b). 
Subsequently Aneurysmal disease augmented by 
dynamic vascular remodeling in response to normal 
pulsatile shear stress, growth factor and cytokines may 
occur (Krizanac-Bengez et al., 2004). Undercurrent 
opportunistic infections may contribute to the production 
of necessary cytokines that drive this process (Tipping 
et al., 2007a). Additionally, recent Danish study, found 
that, HIV positive patients have a higher risk for stroke, 
especially those with severe disease as determined by 
lower CD4 cell count (Rasmussen. 2011) 
 
METHODOLOGY 
This was a hospital-based, case-control study. The 
study population consisted of two groups namely: 
cases; who were patients with stroke presenting to 
University of Maiduguri Teaching Hospital (UMTH), and 
controls; who were healthy volunteers living in 
Maiduguri. Clearance was obtained from the Ethical 
Committee of the University of Maiduguri Teaching 
Hospital. One hundred and thirty subjects were enrolled 
made up of, sixty five consecutive cases and sixty five 
controls. Criteria for inclusion into the study were; (a) 
age above sixteen years, (b) Computed tomographic 
scan evidence of stroke. Previously diagnosed HIV 
Patients with computed tomographic scan evidence of 
intracranial lesions other than stroke were excluded.  
A standard questionnaire was administered to each 
study participant after seeking an informed consent. 
Information including, age, sex, occupational status and 
level of education, was obtained. Others Included 
cigarette smoking, alcohol consumption, current use of 
drugs such as cocaine and amphetamine, and use of 
oral contraceptives in women. Information about a prior 
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physician diagnosis of medical conditions, such as 
hypertension, diabetes, sickle cell disease, renal failure, 
congestive cardiac failure, and car
obtained 
All study participants were physically examined by the 
investigators, and records made of the subject's weight, 
height, pulse rate, pulse rhythm, blood pressure, 
cardiac status oral thrush and lymphadenopathy. 
Results of investigations were recorded. These 
included a brain CT scan in the case of stroke cases, 
fasting blood glucose resting ECG and cholesterol 
level. Blood samples were taken for HIV 1&2 screening 
using ELISA method. Positive results were confirmed 
by double ELISA. CD4 was determined by western blot 
method 
Statistical analysis was done using SPSS version 11
Risk factors for stroke were tested for Odds ratio. 
Means of two groups were compared using student's t
test while proportions were compared using chi
with Yates correction where appropriate. Any p
less than 0.05 was considered significant.   
RESULTS 
One hundred and thirty subjects were enrolled in this 
study (65 consecutive cases and 65 controls
the cases 36 (55.2%) were males and twenty
(44.8%) were females giving a Male: Female ratio of 
1.4: 1. The age range of the patients was between 20 
and 68 years. The highest stroke frequency (30.8%) 
occurred in the age group 55-64 years, while the lowest 
frequency (6.2%) was observed in the age 
years. The mean age of the stroke patients was 47.22  
SD 13.64 years and controls 42.42 SD 11.14 years 
(Tables 1 and Figure 1) The mean age of stroke 
patients with HIV disease (36.38±11.37 years) was
significantly (P < 0.001) lower than that of
patients without AIDS disease  (49.92±12.87 years
Thirteen (20%) out of 65 stroke patients were HIV 
positive as against three (4.6%) among controls p< 
0.016.  
The mean CD4 count of HIV positive stroke patient was 
224.92 cells/µl, in comparison the mean CD
HIV negative patients (690.67 cells/
(9/13, 69%) HIV positive stroke patients have CD
count of < 200 cells/µl while the remaining four (4/13, 
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Figure 1: Bar-chart of age and sex distribution of cases  
Figure 2: Pie-chart of risk factors for stroke
Table 2: Mean CD4 Count 
Control. 
Mean CDHIV status 
HIV+ve 
HIV-ve 
(F, 11.22;  P<.001). 
DISCUSSION 
The frequency (20%) of HIV infection among 
patients in this study is remarkably similar to the 18% 
found in a retrospective study among black Africans 
(Mochan et al., 2003) and 15% of all strokes in young 
HIV-infected black Africans in KwaZulu
of South Africa (Hoffmann 
findings of this study supported earlier ones that 
showed that in most parts of Africa, about 25% of cases 
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of stroke occur in young adults and HIV infection is 
becoming an important contributor (Imam 2002). This 
high frequency is probably mediated by increased 
susceptibility of HIV-infected patients to vasculitis and 
the injury is likely to be due to thrombotic (Cole and 
Pinto 2004). In addition, various abnormalities 
predisposing to a hypercoagulable state have also been 
reported in patients with HIV infection (Imam 2002).  
However, the 20% frequency of HIV infection among 
stroke patients in this study is higher than 3.4% 
frequency of stroke among HIV/AIDS patients reported 
by Isezuo in an eight-year review of hospitalized 
patients in Sokoto, north-western Nigeria (Isezuo 2009), 
4% reported in Kinshasa Zaire (Perriens and Mussa 
1992) and 5.4% among Thai young adults (Kiatsak 
2002). It is also higher than 0.5-7% incidence of stroke 
among HIV/AIDS patients in a clinical study in the 
United States of America (Ortiz et al., 2007). This may 
be due to differences in methodology and study areas.  
Findings of low CD4+ cells among HIV infected stroke 
patients in this study is consistent with prior evidence 
that low CD4+T-cell count may increase the risk of 
stroke in HIV-infected patients (Hsue et al., 2004; Baker 
et al., 2007), is also similar to low CD4 count found in 
(77%) black South African HIV positive stroke patients 
(Mochan et al., 2003). Additionally, observational 
studies in other developing countries have suggested 
an association between immune dysfunction and stroke 
based on increased hospital admissions for young 
immunosuppressed HIV-positive patients with ischemic 
stroke in the absence of other obvious risk factors of 
ischemic stroke.(Tipping et al., 2007a; Heikinheimo et 
al., 2012). This suggests the role of degree of 
immunosuppression as a determinant of development 
of neurological manifestation of HIV/AIDS. Furthermore, 
a Danish study found significant increase risk of total 
cerebrovascular events in non-IDU HIV- infected 
individuals with a CD4 count <200 cells/ml who had not 
initiated HAART (Rasmussen LD. 2011) this may  give 
credence to the findings of this study.  
In a related development, Chow et al. (2012), showed 
that HIV was an independent risk factor for ischaemic 
stroke even after adjustment for usual ischemic stroke 
risk factors In a comparative study of ischemic stroke 
incidence in HIV-infected and non-HIV-infected patients 
in  US health care system in 2012. Additionally, CD4 
counts <200 was found to be associated with increased 
stroke risk in treatment naive HIV cohort (Chow et al., 
2012) 
Cole et al., (2004) reported that, CD4 count of < 
200cells/µl is associated with a higher risk for stroke. A 
study among HIV-infected individuals was shown that, a 
low CD4 T-cell count was independently associated with 
an increased prevalence of carotid lesions (Robert et 
al., 2008) which is one of the proposed mechanisms of 
stroke. In addition, earlier study by Mochan et al. 
(2003), demonstrated association between advanced 
immunosuppression and opportunistic infections. 
CONCLUSION 
In addition to the usual risk factors for ischemic stroke 
in HIV-infected patients, immune dysfunction (low CD4 
count) is an important and significant modifiable risk 
factor of ischemic stroke event among HIV infected 
adult population of Northeastern Nigeria. Consequently, 
better understanding and awareness of the role of low 
CD4 count in the pathogenesis of stroke among HIV 
adults in this environment may provide a roadmap for 
controlling one of the deleterious neurologic 
complication of HIV infection 
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